New Cousteau-Linked...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$6.43 0.03 | 0.47%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 57.63M | 150.67M | 94.73M | 73.33M |
| Receivables | 607.00K | 3.50M | 1.42M | 1.82M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 60.26M | 156.81M | 121.27M | 116.98M |
| Property, Plant & Equipment, Gross | 157.33M | 158.25M | 154.44M | 153.96M |
| Accumulated Depreciation & Depletion | 75.26M | 66.72M | 59.00M | 51.22M |
| Property, Plant & Equipment, Net | 82.07M | 91.53M | 95.44M | 102.74M |
| Intangibles | 11.03M | 12.03M | 13.12M | 16.26M |
| Other Non-Current Assets | 3.77M | 5.99M | 6.44M | 5.35M |
| Total Non-Current Assets | 96.87M | 109.56M | 115.00M | 124.35M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 157.13M | 266.36M | 236.28M | 241.33M |
| Accounts Payable | 2.36M | 5.02M | 9.68M | 12.94M |
| Short Term Debt | 1.31M | 18.78M | 717.00K | 410.00K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 14.36M | 36.87M | 20.69M | 47.20M |
| Long Term Debt | 14.70M | 27.40M | 57.05M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 534.00K |
| Other Non-Current Liabilities | 43.05M | 46.31M | 7.21M | 13.31M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 132.21M | 149.48M | 141.02M | 76.50M |
| Total Liabilities | 146.57M | 186.35M | 161.71M | 123.70M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 10.56M | 80.02M | 74.57M | 117.63M |
| Common Par | 15.00K | 12.00K | 10.00K | 8.00K |
| Additional Paid In Capital | 1.11B | 1.09B | 961.27M | 859.37M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -1.08B | -989.12M | -864.59M | -718.94M |
| Treasury Stock | -23.07M | -23.07M | -23.07M | -23.07M |
| Other Equity Adjustments | 4.74M | 4.97M | 945.00K | 256.00K |
| Total Capitalization | 25.26M | 107.42M | 131.62M | 117.63M |
| Total Equity | 10.56M | 80.02M | 74.57M | 117.63M |
| Total Liabilities & Stock Equity | 157.13M | 266.36M | 236.28M | 241.33M |
| Total Common Shares Outstanding | 146.09M | 121.52M | 92.81M | 71.13M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 3.00M | 3.00M | 3.00M | 3.00M |
| Basic Weighted Shares Outstanding | 139.17M | 109.57M | 84.34M | 73.84M |
| Diluted Weighted Shares Outstanding | 139.17M | 109.57M | 84.34M | 73.84M |
| Number of Employees | 266 | 351 | 358 | 499 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Userchrisnash69 Portfolio 1
- User1st Time out
- Userbio
- UserWIDELY HELD IN GAME
- Usermarket watch 2012
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserHoldings
- ContributorStocks Under-$10 Moving Hig...
Latest ARNA Headlines from TheStreet
- Stocks Under $10: Why I'm a Buyer
05.31.12 | 07:05 am - 4 Stocks Under $10 Making Big Moves 05.30.12 | 03:05 pm
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Loser 05.25.12 | 05:05 pm
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Outlooks for Pfizer, Arena and Onyx Following Busy May 05.21.12 | 07:05 am
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Stocks Under $10: Healthcare Name on Sale 05.17.12 | 07:05 am
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Winner 05.14.12 | 04:05 pm
- Mulling Arena Pharma's Future With Obesity Drug on Approval Path 05.14.12 | 03:05 pm
Press Releases for ARNA
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge? - Benzinga 05.31.12 | 12:05 pm
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Pre-Market Most Active for May 22, 2012 : QQQ, NOK, FB, BBY, TEF, BAC, SNY, NVO, VOD, AAPL, ARNA, ZNGA - NASDAQ 05.22.12 | 12:05 pm
- Pre-Market Most Active for May 17, 2012 : SNY, BAC, BUD, MT, MTL, WMT, QQQ, VOD, AAPL, DNDN, ZNGA, ARNA - NASDAQ 05.17.12 | 12:05 pm
- Pre-Market Most Active for May 16, 2012 : CTL, SNY, BAC, GE, NCT, MT, QQQ, ARNA, SINA, PETD, ZNGA, RIMM - NASDAQ 05.16.12 | 12:05 pm
- After Hours Most Active for May 15, 2012 : DFG, TPX, JCP, GSM, QQQ, BAC, ARNA, CCJ, AIG, VELT, INTC, NWSA - NASDAQ 05.15.12 | 08:05 pm
- Pre-Market Most Active for May 14, 2012 : BAC, CHK, NOK, BBVA, CS, SIRI, JPM, ARNA, QQQ, YHOO, AAPL, FRAN - NASDAQ 05.14.12 | 12:05 pm
- Arena Pharmaceuticals: FDA Approval Is Just The Beginning - Seeking Alpha 05.13.12 | 09:05 am
- Benzinga's Top Upgrades with Color for May 11, 2012 - Benzinga 05.11.12 | 12:05 pm
- Social Media Outlook for Wednesday May 9 (PDC, DIS, STEC, FOSL) - Benzinga 05.09.12 | 01:05 pm
